[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349300-105":59,"doc-detail-349300-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gynecologic-tumors-in-thai-women-with-breast-cancer-a-crosssectional-surveillance-and-ten-year-cohort-study","Gynecologic tumors in Thai women with breast cancer - a crosssectional surveillance and ten-year cohort study","","Breast cancer and gynecologic tumors share hormonal and genetic risk factors, yet comprehensive data on overall concurrent and subsequent gynecologic tumors remain limited in Asian populations. This study determined the prevalence of concurrent gynecologic tumors and the incidence of de novo tumors among Thai women with breast cancer. An initial cross-sectional cohort (2007-2009) underwent clinical, cytology, and ultrasonography assessment, followed by a 10-year review for incident de novo tumors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gynecologic-tumors-in-thai-women-with-breast-cancer-a-crosssectional-surveillance-and-ten-year-cohort-study/349300/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gynecologic-tumors-in-thai-women-with-breast-cancer-a-crosssectional-surveillance-and-ten-year-cohort-study/349300.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study designed to evaluate in Thai women with breast cancer?","Question",{"text":112,"@type":113},"The study evaluated the prevalence of concurrent gynecologic tumors and the incidence of de novo gynecologic tumors over follow-up in Thai women with breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were gynecologic tumors assessed at baseline?",{"text":117,"@type":113},"Participants were investigated using clinical examination, cervical cytology testing, and pelvic ultrasonography, with additional procedures as indicated.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key prevalence and incidence findings?",{"text":121,"@type":113},"Concurrent gynecologic tumors were found in 114 of 281 women (40.6%). During 10-year follow-up, de novo gynecologic tumors occurred at an incidence of 3.1 per 100 person-years, with metachronous cancers at 1.4 per 100 person-years.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349300,1790193648,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Original Article  \nGynecologic tumors in Thai women with breast cancer: a crosssectional surveillance and ten-year cohort study  \nPreeyaporn Jirakittidul1^, Manee Rattanachaiyanont1^, Suchada Indhavivadhana1^, Chongdee Dangrat1^, Patsama Vichinsartvichai1^, Visnu Lohsiriwat2^  \n1Gynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 2Division of Head-Neck and Breast Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand  \nContributions: (I) Conception and design: M Rattanachaiyanont, P Jirakittidul, P Vichinsartvichai, V Lohsiriwat; (II) Administrative support: M Rattanachaiyanont, V Lohsiriwat; (III) Provision of study materials or patients: M Rattanachaiyanont; (IV) Collection and assembly of data: PJirakittidul, P Vichinsartvichai, S Indhavivadhana, C Dangrat, V Lohsiriwat; (V) Data analysis and interpretation: M Rattanachaiyanont; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Prof. Manee Rattanachaiyanont, MD. Gynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of  \nMedicine Siriraj Hospital, Mahidol University, 2 Wanglung Rd., Bangkok, 10700, [Thailand. Email: manee.rat@mahidol.ac.th](Thailand. Email: manee.rat@mahidol.ac.th).  \nBackground: Breast cancer and gynecologic tumors share common hormonal and genetic risk factors.  \nPrevious studies mainly focused on the risk of endometrial pathology in women receiving tamoxifen, while the data on the overall prevalence of concurrent and subsequent gynecologic tumors in patients with breast cancer, especially in Asian populations, remain limited. Clarifying this association is important to survey the prevalence of concurrent gynecologic tumors and the incidence of de novo tumors in Thai women with breast cancer. This study aimed to determine the prevalence of concurrent gynecologic tumors and the incidence of  \nde novo gynecologic tumors in Thai women with breast cancer.  \nMethods: An initial cross-sectional study was conducted at the Faculty of Medicine Siriraj Hospital, Mahidol University. Participants were women scheduled for breast cancer surgery between September 2007 and January 2009. They were investigated for gynecologic tumors using clinical examination, cervical cytology testing, and pelvic ultrasonography; additional procedures were as indicated. In 2019, data from this  \ncohort were reviewed for the de novo gynecologic tumors arising during the previous 10 years.  \nResults: Concurrent gynecologic tumors were identified in 114 of 281 women (40.6%) with newly diagnosed breast cancer; most tumors were benign, including leiomyoma, adenomyosis, endometrial polyp, and ovarian tumor. Synchronous genital cancers were found in two cases, giving a prevalence of 0.7%[95% confidence interval (CI): 0.3–1.7] . During the 10-year follow-up period, de novo gynecologic tumors were found at an incidence of 3.1 per 100 person-years (95% CI: 2.1–4.4) . Metachronous genital cancers were found in three cases, giving an incidence of 1.4 per 100 person-years (95% CI: 0.3–4.2). The risk of having  \neither concurrent or de novo gynecologic tumors was associated with earlier age at menarche.  \nConclusions: Gynecologic tumors are prevalent in Thai women with breast cancer. The second primary genital cancers, both synchronous and metachronous, are not uncommon. Therefore, surveillance for the concurrent gynecologic tumors and further follow-up for the de novo ones should be considered in these  \npatients.  \nKeywords: Gynecologic tumors; breast cancer; ovarian cancer; endometrial cancer; synchronous cancer  \n^ ORCID: Preeyaporn Jirakittidul, 0000-0003-0221-9789; Manee Rattanachaiyanont, 0000-0002-4533-9249; Suchada Indhavivadhana, 0000-0002-6658-100X; Chongdee Dangrat, 0000-0002-1218-3532; Patsama Vichinsartvichai, 0000-0002-4501-9384; Visnu Lohsiriwat, 0000-000","cbCaigctJZf8JtwB","https://ap.wps.com/l/cbCaigctJZf8JtwB","pdf",639532,"English","# Background\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What was the study designed to evaluate in Thai women with breast cancer?\",\"answer\":\"The study evaluated the prevalence of concurrent gynecologic tumors and the incidence of de novo gynecologic tumors over follow-up in Thai women with breast cancer.\"},{\"question\":\"How were gynecologic tumors assessed at baseline?\",\"answer\":\"Participants were investigated using clinical examination, cervical cytology testing, and pelvic ultrasonography, with additional procedures as indicated.\"},{\"question\":\"What were the key prevalence and incidence findings?\",\"answer\":\"Concurrent gynecologic tumors were found in 114 of 281 women (40.6%). During 10-year follow-up, de novo gynecologic tumors occurred at an incidence of 3.1 per 100 person-years, with metachronous cancers at 1.4 per 100 person-years.\"}]","Gynecologic tumors in Thai women with breast cancer - a crosssectional surveillance and ten-year cohort study | PDF",1790082652,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/912806d5bd4d74145629fac579cd87ed.webp",983,1287,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc42563103bacc981064cf883aea9d33.webp",982,1286,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92f8a65ab5fff74b0389b3fba0c7bd49.webp",981,1284,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1153c5c6363972c37d20329dd9a70448.webp",980,1283]